ALDH1A1 and breast carcinoma: Given that ALDH1 has been both correlated with metastatic disease and shown to functionally contribute to metastasis, it may be beneficial to use assessment of ALDH1 expression in the primary tumor as a clinical tool for identifying breast cancer patients with a high risk of metastasis and stratifying them for aggressive therapy to prevent disease recurrence or progression.